Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report
Braz. j. infect. dis
;
13(2): 158-160, Apr. 2009.
Artículo
en Inglés
| LILACS
| ID: lil-538225
ABSTRACT
Multidrug therapy (WHO/MDT) in multibacillary leprosy consists of treatment with rifampicin, dapsone andclofazimine. However, adverse effects can cause the patient to abandon treatment. We report on a patient whopresented agranulocytosis and hemolytic anemia associated with this treatment regime. We also examined theimportance of laboratory exams for diagnosis and follow-up of the patient, and for early detection of adverse effects, with a view to improving adhesion to treatment and contributing to the eradication of Hansens disease as a public health issue.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Agranulocitosis
/
Anemia Hemolítica
/
Leprostáticos
Tipo de estudio:
Estudio de tamizaje
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Braz. j. infect. dis
Asunto de la revista:
Enfermedades Transmisibles
Año:
2009
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Federal University of Paraíba/BR
/
Medicine School Nova Esperança/BR
Similares
MEDLINE
...
LILACS
LIS